Page last updated: 2024-10-23

berberine and Frontotemporal Lobar Degeneration

berberine has been researched along with Frontotemporal Lobar Degeneration in 1 studies

Frontotemporal Lobar Degeneration: Heterogeneous group of neurodegenerative disorders characterized by frontal and temporal lobe atrophy associated with neuronal loss, gliosis, and dementia. Patients exhibit progressive changes in social, behavioral, and/or language function. Multiple subtypes or forms are recognized based on presence or absence of TAU PROTEIN inclusions. FTLD includes three clinical syndromes: FRONTOTEMPORAL DEMENTIA, semantic dementia, and PRIMARY PROGRESSIVE NONFLUENT APHASIA.

Research Excerpts

ExcerptRelevanceReference
"Here we studied the molecular mechanism of berberine in cell culture model with TDP-43 proteinopathies, and found that berberine is able to reverse the processing of insoluble TDP-43 aggregates formation through deregulation of mTOR/p70S6K signal and activation of autophagic degradation pathway."3.83Therapeutic effect of berberine on TDP-43-related pathogenesis in FTLD and ALS. ( Chang, CF; Chen, CL; Huang, CC; Lee, KH; Lee, YC; Lin, HC; Shen, CJ, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, CF1
Lee, YC1
Lee, KH1
Lin, HC1
Chen, CL1
Shen, CJ1
Huang, CC1

Other Studies

1 other study available for berberine and Frontotemporal Lobar Degeneration

ArticleYear
Therapeutic effect of berberine on TDP-43-related pathogenesis in FTLD and ALS.
    Journal of biomedical science, 2016, Oct-21, Volume: 23, Issue:1

    Topics: Amyotrophic Lateral Sclerosis; Animals; Berberine; Cell Line, Tumor; Frontotemporal Lobar Degenerati

2016